Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30a442baf6f7cfcfda551848c4fc6df4 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
filingDate |
2011-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0f4f646e1f9f30af7603b448b919c30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be826391a283375a616f1f7d47c95f0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_247e8c8bc05331d8e7bb8e6956a66579 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0c3a70c0a7f47f7b9378670bc303d2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5229fdf8f55f49a71eea3ed3c8cdaf8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cd330b876f87251aa120766fb3770e6 |
publicationDate |
2013-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20130130727-A |
titleOfInvention |
Compositions of rotigotine, derivatives thereof or pharmaceutically acceptable salts of rotigotine or derivatives thereof |
abstract |
The present invention relates to rotigotine or a pharmaceutically acceptable salt thereof; One or more poly (lactide-co-glycolide) (PLGA); And at least one fatty acid, wherein the at least one fatty acid is at least 0.5% by weight based on the total weight of the composition. In addition, the compositions described herein significantly reduce the burst release effect. The invention also provides a method of treating Parkinson's disease comprising administering to a subject in need thereof an effective amount of a composition as described herein. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020105883-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019088744-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200059809-A |
priorityDate |
2010-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |